2015
DOI: 10.1021/acs.jmedchem.5b00262
|View full text |Cite
|
Sign up to set email alerts
|

Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents

Abstract: A series of novel hexacyclic tetracycline analogues ("hexacyclines") was designed, synthesized, and evaluated for antibacterial activity against a wide range of clinically important bacteria isolates, including multidrug-resistant, Gram-negative pathogens. Valuable structure-activity relationships were identified, and several hexacyclines displayed potent, broad spectrum antibacterial activity, including promising anti-Pseudomonas aeruginosa activity in vitro and in vivo.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(19 citation statements)
references
References 20 publications
0
19
0
Order By: Relevance
“…Of all the compounds studied, the best results were recorded for C7-fluorohexacycline and C7-trifluoromethoxyhexacycline, with a broad antibacterial activity in vitro and good activity in vivo on Pseudomonas aeruginosa. The promising data extracted from this study support the optimisation of this type of skeleton to discover and obtain in the future some new tetracyclines that are clinically valuable [182].…”
Section: New Compounds Under Developmentmentioning
confidence: 58%
“…Of all the compounds studied, the best results were recorded for C7-fluorohexacycline and C7-trifluoromethoxyhexacycline, with a broad antibacterial activity in vitro and good activity in vivo on Pseudomonas aeruginosa. The promising data extracted from this study support the optimisation of this type of skeleton to discover and obtain in the future some new tetracyclines that are clinically valuable [182].…”
Section: New Compounds Under Developmentmentioning
confidence: 58%
“…More recently, a fully synthetic chemistry approach has led to the discovery of eravacycline, which shows promise in the treatment of serious infections caused by a broad range of bacterial pathogens. Ongoing exploration of synthetic tetracycline derivatives has enabled improvements in potency against P. aeruginosa and other difficult-to-treat MDR Gram-negative pathogens (Deng et al 2012;O'Brien et al 2012;Xiao et al 2013;Grossman et al 2014a;Sun et al 2014aSun et al , 2015. The ability to synthesize completely novel, "unnatural" tetracyclines opens new opportunities to more fully explore the potential of this familiar and clinically validated antibiotic class.…”
Section: Resultsmentioning
confidence: 99%
“…156 More recently, the Myers group published a modified synthetic route to 5-oxytetracycline derivatives, which were hypothesized to enhance activity against Gram-negative strains thanks to an increase in polar surface area. 157 However, these compounds did not show an increase in potency, which might be attributed to poor aqueous stability.…”
Section: From Benchtop To Bedside—innovations In the Tetracyclinesmentioning
confidence: 99%